We're attending the AACC, Anaheim in July 2023. Schedule a meeting with the team.

Thermo Scientific bids for Life Technologies

Exot Strategy 2

Thermo Fisher Scientific Inc is thought to have made a binding offer of $65 per share for Life Technologies Corp on Tuesday. More information regarding the deal is available through Reuters. Update as of 15/04/2013: Thermo Fisher Scientific (NYSE: TMO), the world leader in serving science, and Life Technologies Corporation (NASDAQ: LIFE), a leading life … Read more

Rockland, Inc. acquires Epi-Plus product line from 21st Century Biochemicals

Exit Strategy 5

Rockland now manufactures antibodies from the Epi-Plus® epigenetics line that can assist in various types of cancer research. Epigenetic alterations are extremely important to a cell’s transformation to cancer, and the mechanisms of epigenetic silencing of tumor suppressor genes and activation of oncogenes holds great promise for cancer prevention, detection, and therapy. Rockland epigenetic antibodies … Read more

OriGene acquires SDIX Life Science Assets

Exit Strategy 3

OriGene announced that it has recently signed a definitive agreement to acquire all of the assets of the Life Sciences business of SDIX (Strategic Diagnostics, Newark DE). The combination of SDIX and OriGene expands the company’s ability to develop the most comprehensive collection of high-quality monoclonal antibodies for key applications in research and diagnostic fields. … Read more